Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Public Health|September 12, 2020
Social norms for e-cigarettes and smoking: associations with initiation of e-cigarette use, intentions to quit smoking and quit attempts: findings from the EUREST-PLUS ITC Europe SurveysMáirtín S McDermott, Katherine A East, Sara C Hitchman, et al.
Epilepsia Open|May 25, 2021
Brain-Responsive Neurostimulation for the treatment of adults with epilepsy in tuberous sclerosis complex: A case seriesDanielle S McDermott, Emily A Mirro, Kirsten Fetrow, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Expression and localization of NMDA receptor GluN2 subunits in dorsal horn pain circuits across sex, species, and late postnatal developmentJennifer Armstrong, Katherine Griffiths, Newton Martin, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptorStephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Oncogene|June 13, 2017
EMP2 is a novel therapeutic target for endometrial cancer stem cellsM H Kiyohara, C Dillard, J Tsui, et al.
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 21, 2026
Expression and localization of NMDA receptor GluN2 subunits in dorsal horn pain circuits across sex, species, and late postnatal developmentKatherine Griffiths, Jennifer Armstrong, Newton Martin, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonistsHanh Nho Nguyen, Howie Bregman, John L Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiatorsBrian K Albrecht, Virginia Berry, Alessandro A Boezio, et al.
European Urology Oncology|July 10, 2021
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 TrialBrian I Rini, Michael B Atkins, Elizabeth R Plimack, et al.
Pageof 20